ClinicalTrials.Veeva

Menu

Influence of Thyroid Hormones on the Woundhealing Process

H

Hannover Medical School (MHH)

Status

Unknown

Conditions

Thyroid Carcinoma
Thyroid Neoplasms

Treatments

Procedure: blood sampling

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00929318
MHH-THY-WH-09

Details and patient eligibility

About

Main goal of this clinical investigation is to investigate different cytokines in wound fluids of euthyroid vs. hypothyroid patients. As a primary endpoint we want to evaluate if different cytokine levels in euthyroid vs. hypothyroid patients exist and to what extent these cytokines differ. Our targeted cytokines are: IL6, IL10, TNFa and MCP-1. From the literature these 4 factors seem to be the most reasonable to measure and to focus on. Additionally we focus on these 4 factors for financial reasons, technically there wouldn't be a problem to measure more, which is correlated with higher costs. Besides, more than 6 factors would mean larger amounts of sample fluids needed, which would cause technical problems. These factors don't have to change in the same direction. Secondarily, we believe that differences in cytokine profiles of hypothyroidism vs. euthyroidism will correlate to differences in duration and clinical characteristics of the wound healing process.

Enrollment

26 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Near total or total thyroidectomy because of struma multinodsa (nodular goiter) with or without substitution of thyroid hormone after operation
  • Total thyroidectomy because of papillary carcinoma of thyroid gland (T1/T2 carcinoma, N1, M0) with planned radio-ablative therapy (RAT) without or with rhTSH

Exclusion criteria

  • Pat< 18 years
  • Immune disease of thyroid gland (Graves disease)
  • Severe immunodeficiency
  • Immunosuppressive medication because of solid Organ transplantation
  • Hepatitis A/B/C or HIV
  • All exclusion criteria for any surgical procedure

Trial design

26 participants in 2 patient groups

benign
Active Comparator group
Description:
patients after surgery because of a benign disease
Treatment:
Procedure: blood sampling
Procedure: blood sampling
DTC
Active Comparator group
Description:
Patients after thyroidectomy because of papillary carcinoma of the thyroid gland
Treatment:
Procedure: blood sampling
Procedure: blood sampling

Trial contacts and locations

1

Loading...

Central trial contact

Georg FW Scheumann, Prof; Stephan S Kaaden, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems